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Summary
The Hedgehog (Hh) pathway plays important roles
during embryogenesis and carcinogenesis. Here, we
show that ablation of the mouse Suppressor of fused
(Sufu), an intracellular pathway component, leads to
embryonic lethality atwE9.5 with cephalic and neural
tube defects. Fibroblasts derived from Sufu2/2 em-
bryos showed high Gli-mediated Hh pathway activity
that could not be modulated at the level of Smooth-
ened and could only partially be blocked by PKA acti-
vation. Despite the robust constitutive pathway activa-
tion in the Sufu2/2 fibroblasts, the GLI1 steady-state
localization remained largely cytoplasmic, implying
the presence of an effective nuclear export mecha-
nism. Sufu+/2 mice develop a skin phenotype with ba-
saloid changes and jaw keratocysts, characteristic
features of Gorlin syndrome, a human genetic disease
linked to enhanced Hh signaling. Our data demon-
strate that, in striking contrast to Drosophila, in mam-
mals, Sufu has a central role, and its loss of function
leads to potent ligand-independent activation of the
Hh pathway.
Introduction
The important roles that the Hedgehog (Hh) signaling
pathway plays in embryonic development and tumori-
genesis are well established (Hooper and Scott, 2005;
Ingham and McMahon, 2001; Lum and Beachy, 2004).
The core components of the pathway have been identi-
fied in most invertebrate and vertebrate animals studied
and therefore have been viewed as an evolutionary well-
conserved pathway. Signal transduction is initiated by
binding of the extracellular Hh ligands to the 12-span
transmembrane receptor Patched (Ptch), relieving the
*Correspondence: rune.toftgard@biosci.ki.se (R.T.);stephan.teglund@
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4 These authors contributed equally to this work.repressive effects that Ptch normally exerts upon the
7-span transmembrane protein Smoothened (Smo)
(Ingham and McMahon, 2001). Signal transmission
from Smo eventually leads to changes in the activity of
the Ci/Gli transcription factors that ultimately decide
the outcome of the Hh signal. In the pathway, down-
stream of Smo, a number of components are present
that integrate the signal from Smo and regulate the sta-
tus of Ci/Gli. Initially identified in Drosophila, these
include the serine-threonine kinase Fused (Fu), Sup-
pressor of fused (Sufu), and the microtubule binding ki-
nesin-like molecule Costal 2 (Cos2). Sufu is a negative
regulator of Hh signaling with a proposed role in nu-
clear-cytoplasmic shuttling of the Ci/Gli transcription
factors (Kogerman et al., 1999). There appear to be
two domains in Sufu, one in the NH2 terminus and one
in the COOH terminus, that are important for interacting
with and regulating Ci/Gli (Dunaeva et al., 2003; Mer-
chant et al., 2004).
Human SUFU has been suggested to be a tumor sup-
pressor gene based on the findings in a screen of 46 me-
dulloblastoma tumors (Taylor et al., 2002). In 4 out of
these 46 medulloblastomas, truncating mutations in
the SUFU gene were found, of which 2 were germline
mutations. However, in another screen of 145 primitive
neuroectodermal tumors, including 134 medulloblasto-
mas and 11 medulloblastoma-derived cell lines, no so-
matic or germline mutations in SUFU were found
(Koch et al., 2004), suggesting that genetic alteration
of SUFU is a relatively rare event in human medulloblas-
tomas.
In Drosophila, loss-of-function mutation in Su(fu) sup-
presses the effects of mutations in fu, but, in the ab-
sence of other mutations, it results in essentially no al-
tered phenotype (Ohlmeyer and Kalderon, 1998; Preat,
1992). In zebrafish, genetic ablation (Koudijs et al.,
2005) or morpholino (MO) knockdown of Sufu revealed
a relatively weak repressor activity in the Hh pathway ac-
companied by only slight upregulation of Ptch1 expres-
sion (Tay et al., 2005; Wolff et al., 2003).
In order to gain insight into the role that Sufu plays in
mammals, we have disrupted theSufugene in the mouse
by using gene targeting in embryonic stem cells (ESCs),
and we revealed an essential role for Sufu in the mamma-
lian Hh signaling pathway, demonstrating a fundamental
evolutionary divergence in regulation of Hh signaling.
Results
Sufu2/2 Embryos Die In Utero atwE9.5
To gain insight into the function of Sufu in mammals, ho-
mologous recombination in mouse ESCs was used to
generate mice with a functional ablation of the Sufu
gene (see the Supplemental Data available with this arti-
cle online). Unexpectedly, embryos homozygous for the
Sufu null allele die in utero around E9.5 and exhibit a se-
verely deformed cephalic region that includes an open
fore-, mid-, and hindbrain and neural tube (Figures 1D–
1F). Compared to other mouse Hh pathway loss-
of-function mutants, there is a striking similarity to
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188Figure 1. Sufu2/2 Embryos Die In Utero atwE9.5, and the Neural Tube and Cephalic Vesicles Fail to Completely Close
(A–I) (A, D, and G) Wild-type (wt), Sufu2/2, and Ptch12/2 E9.5 embryos. (B, E, and H) SEM analysis showing the open hindbrain and the anterior
neuropore (arrows) in the Sufu2/2 and Ptch12/2 embryos. (C, F, and I) Formalin-fixed and hematoxylin-eosin-stained transverse sections from
the cephalic region showing lack of closing and properly forming cephalic vesicles in both Sufu2/2 and Ptch12/2 embryos. However, the anterior
Sufu2/2 neuroepithelium forms a wider, more open structure with considerably less mesenchymal tissue compared to the Ptch12/2 embryos.
Anterior is to the left, and posterior is to the right. The scale bar is 100 mm.Ptch12/2 embryos, which die around the same age and
have similar morphology (Goodrich et al., 1997) (Figures
1G–1I). See the Supplemental Data for a detailed ac-
count of the morphological and histological findings.
Constitutive Activation of the Hh Pathway
in the Sufu2/2 Embryos
To investigate whether global changes in expression of
Hh pathway components can be found in the Sufu2/2
embryos, we used in situ hybridization on whole-mounts
and sections in E8.5 (data not shown) and E9.5 embryos
(Figure 2). Strikingly, there was a significant change in
the expression pattern of both Ptch1 and Gli1, particu-
larly along the entire neural tube, where the expression
domain was much broader and extended dorsally (Fig-
ures 2E, 2K, and 3N) compared to wild-type (wt) em-
bryos (Figures 2D, 2J, and 3M). Moreover, the Gli1 ex-
pression pattern was very similar in both Sufu2/2 and
Ptch12/2 embryos (Figures 2K and 2L). The expression
of both Gli2 and Gli3 in the cephalic region was absent
in the Sufu2/2 embryos, consistent with the fact that
the cephalic neural folds did not close (Figures 2N and
2Q). Besides the cephalic region, in the rest of the em-
bryo, including the neural tube, there was a marked
lower overall expression of Gli3 (Figures 2Q and 3P). In
contrast, particularly in the caudal region, Gli2 expres-
sion remained detectable (Figure 2N). Sufu expression
is normally rather widespread (Figure 2G), and no majorchanges occur in the Ptch12/2 embryos (Figure 2I), sug-
gesting that Sufu is not itself a transcriptionally regu-
lated Hh target gene.
Sufu2/2 Embryos Develop a Ventralized Neural Tube
The role of Hh signaling activity in patterning of the dor-
soventral aspects of the developing neural tube is well
characterized (Briscoe and Ericson, 2001). Shh secreted
from the notochord and floor plate forms a dorsoventral
gradient that translates into a gradient of Gli activity.
This, in turn, controls cell fate and the position of the dif-
ferent neuronal subtypes of the ventral neural tube (Sta-
mataki et al., 2005). In Ptch12/2 embryos, the neural
tube is ventralized (Goodrich et al., 1997). To gain insight
into how loss of Sufu affects levels of Hh signaling, we
investigated possible qualitative and/or quantitative dif-
ferences in the patterning of the E9.5 Sufu2/2 neural
tube compared to Ptch12/2 and wt embryos.
FoxA2 (Hnf3b), a winged-helix transcription factor, is
important for floor plate (FP) development in the neural
tube and is also a marker, albeit not a definitive one,
for FP cells (Placzek and Briscoe, 2005) (Figure 3D). In
the Sufu2/2 neural tube, FoxA2 was expressed along
the entire dorsoventral axis (Figure 3E), suggesting
that, like in Ptch12/2 embryos (Figure 3F), the neuroepi-
thelium has adopted a ventralized identity. However, as
shown by using the more definitive FP marker NK1R,
a substance P receptor (data not shown), and Nato3
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189(Figure 3R), not all cells in the neural tube were bona fide
FP cells. The FP cells normally express Shh (Placzek and
Briscoe, 2005) (Figure 3A), regulated by a FP-specific
enhancer in the Shh gene, which contains FoxA binding
sites (Jeong and Epstein, 2003). Indeed, the expanded
Figure 2. Ectopic Activation of Hh Target Genes and Aberrant Ex-
pression of Other Hh Pathway Components in Sufu2/2 Embryos
Mimicking that Seen in Ptch12/2 Embryos
(A–R) Whole-mount in situ hybridizations of wild-type (wt), Sufu2/2,
and Ptch12/2 E9.5 embryos with DIG-labeled antisense riboprobes
against (A–C) Shh, (D–F) Ptch1, (G–I) Sufu, (J–L) Gli1, (M–O) Gli2, and
(P–R) Gli3.FoxA2 domain corresponded to the dorsal expansion
of the Shh protein and mRNA expression (Figure 3B
and Figure S3).
To understand whether the different neuronal sub-
types were forming in theSufu2/2 neural tube, we immu-
nostained for the Nkx2.2 and Nkx6.1 homedomain pro-
teins, both of which were misexpressed along the
entire dorsoventral axis (Figures 3H and 3K) compared
to wt (Figures 3G and 3J), mirroring the expression
seen in the Ptch12/2 neural tube (Figures 3I and 3L).
The homedomain protein Isl1/2 is normally expressed
in the motor neuron (MN) domain, and the number of
Isl1/2 immunoreactive cells in the Sufu2/2 (Figure 3E)
andPtch12/2 neural tube (Figure 3F) appears rather sim-
ilar to wt (Figure 3D). However, in both mutants, the Isl1/
2-positive cells are scattered along the dorsoventral axis
rather than confined to the discrete MN domain. In con-
trast, the homedomain protein Pax6, normally ex-
pressed in the dorsal neural tube, was essentially lost
in both Sufu2/2 (Figure 3H) and Ptch12/2 (Figure 3I)
compared to wt (Figure 3G). However, in the region of
neural tube closure, Ptch12/2 mutants display Pax6 ex-
pression at the most dorsal region (data not shown), as
has been described before (Bai et al., 2002). These data
demonstrate that theSufu2/2neural tube shows a strong
ventralization, with most neuronal cells committed to
a ventral fate.
The Constitutive Gli Activity in the Sufu2/2 MEFs
Is Unaffected by Either a Smoothened Agonist
or Antagonist and Is Partially Sensitive
to PKA Inhibition
To further explore the Sufu-dependent Hh signaling de-
fects in more detail, we analyzed embryonic fibroblast
(MEF) cell lines established from Sufu+/+ (wt), Sufu+/2,
and Sufu2/2 E9.5 embryos with the same genetic back-
ground. Ptch12/2 MEFs were used in comparison (Tai-
pale et al., 2000). The expression of the Hh target genes
Ptch1,Gli1, and, to some extent, Ptch2 was upregulated
in the Sufu2/2 MEFs compared to the wt MEFs, as
shown by RT-PCR (Figure 4A); this finding is consistent
with the constitutively active Hh signaling seen in the
embryos. A similar expression pattern was seen in the
Ptch12/2 MEFs. Gli2 and Smo expression remained un-
changed in the Sufu2/2 as well as the Ptch12/2 MEFs
compared to wt. The absence of Sufu mRNA in the
Sufu2/2 MEFs was confirmed, and the expression of
Sufu was not altered in the Ptch12/2 MEFs (Figure 4A).
To assess the activity of the Gli transcription factors
in the MEFs, we used a luciferase assay with reporter
plasmids containing eight wt (83GliLuc) or mutant
(83GlimutLuc) Gli binding sites in tandem (Sasaki et al.,
1997). Both Sufu2/2 MEF lines #1 and #2 showed a sim-
ilarw12- to 15-fold increase in reporter activity relative
to wt MEFs (Figure 4B). This increased activity is depen-
dent on intact Gli binding sites since the 83GlimutLuc re-
porter gave essentially no significant activity above that
found in wt MEFs (Figure 4B).
We next asked if we could rescue the phenotype of the
Sufu2/2 MEF cells and repress the increased Gli activity
by reintroducing Sufu. Transient transfection of human
SUFU caused a reduction in Gli activity to wt levels
(Figure 4B). This demonstrates that the observed phe-
notype is Sufu dependent and not due to other genetic
Developmental Cell
190Figure 3. Ventralization of the Sufu2/2 Embryonic Neural Tube Similar to that Seen in Ptch12/2 Embryos
(A–L) Transverse sections of the neural tube at the thoracic level of wild-type (wt), Sufu2/2, and Ptch12/2 E9.5 embryos immunofluorescently
stained with antibodies against (A–C) Shh (red), (D–F) FoxA2 (red) and Isl1/2 (green), (G–I) Nkx2.2 (green) and Pax6 (red), and (J–L) Nkx6.1 (green).
(M–R) In situ hybridization of neural tube sections of wt and Sufu2/2 E9.5 embryos hybridized with DIG-labeled riboprobes against (M and N)
Ptch1, (O and P) Gli3, and (Q and R) Nato3.alterations in the ES cells or MEF cells. Furthermore, it
shows that human SUFU can functionally substitute for
mouse Sufu.
To address the question of whether the observed Gli-
mediated Hh signaling activity in the Sufu2/2 MEF cells
can be further stimulated, we incubated the Sufu2/2
MEF cells with or without a concentration of Smo ago-
nist (SAG) that has been shown to fully activate the Hh
pathway (Chen et al., 2002). No further increase in Gli re-
porter activity could be observed (Figure 4C), suggest-
ing that in the absence of Sufu, activation of Smo could
not induce additional Gli-mediated transcriptional activ-
ity. Conversely, we tested whether cyclopamine, a
known inhibitor of the Hh pathway that acts on Smo,
could inhibit Gli reporter activity (Taipale et al., 2000).
However, again, no effect was observed (Figure 4C), in-
dicating that neither stimulation nor inhibition of the Hh
pathway at the level of Smo has any significant effect
on Gli activity in the absence of Sufu.
Protein kinase A (PKA) is known to negatively affect
Hh signaling. To test whether PKA has such an effect
in cells lacking Sufu, we treated MEF cells with forskolin,
a known activator of PKA, and could inhibit the Gli-
mediated response, but only by w50% (Figure 4D).The same result was obtained by expressing a constitu-
tively active form of the catalytic subunit of PKA. In con-
trast, an almost complete suppression was observed in
the Ptch12/2 MEFs (Figure 4D), as has been shown be-
fore (Taipale et al., 2000). An inhibitor of PKA, H-89, as
expected had no significant effect on the Gli response
(Figure 4D).
EGFP::GLI1 Localizes Predominantly
in the Cytoplasm of Sufu2/2 MEFs
One of the proposed roles for Sufu is to retain Gli pro-
teins in the cytoplasm. To determine the subcellular lo-
calization of GLI1 in the absence of Sufu, we transiently
transfected the MEF cells with GLI1 fused to EGFP
(EGFP::GLI1) to visualize the protein. EGFP::GLI1 local-
ized predominantly in the cytoplasm of Sufu2/2 MEFs,
and no significant difference to wt and Ptch12/2 MEFs
was observed (Figure 4E). Transfection of the parental
EGFP plasmid gave a different localization pattern,
which was both cytoplasmic and nuclear (Figure 4E), in-
dicating that the localization we observed is GLI1 spe-
cific and not a property of the EGFP protein.
The nuclear export of Gli proteins is dependent on Crm1
(Kogerman et al., 1999), which facilitates the translocation
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191Figure 4. GLI1 Predominantly Resides in the Cytoplasm of Sufu2/2 MEFs, Whose Constitutive Hh Pathway Activity Cannot Be Modulated at the
Level of Smo and Can Be Partially Blocked by PKA
(A) Agarose gel analysis of RT-PCR reactions from Sufu+/+ (wt), Sufu2/2 cell line #1, and Ptch12/2 MEFs with primers specific for Ptch1, Ptch2,
Smo, Sufu, Gli1, and Gli2. Primers for Hprt were used as a control for RNA input levels.
(B) Transient transfection of Sufu wt (+/+) and mutant (2/2) MEF lines #1 and #2 with 83GliLuc (filled columns) or 83GlimutLuc (open columns)
luciferase reporter plasmids with (+) or without (2) the pMYC-SUFU expression plasmid. Gli reporter activity, which was given an arbitrary level of
1.0, is presented relative to wt MEFs after compensating for transfection efficiency by using the Renilla luciferase reporter plasmid. Results are
means 6 standard deviation (SD) of the mean of at least three independent experiments.
(C) Treatment of wt, Sufu2/2 cell line #1, andPtch12/2MEFs with 10 mM cyclopamine (shaded column), 100 nM Smoothened agonist (SAG) (black
column), or with DMSO alone (open column) for 2 days prior to measuring 83GliLuc reporter activity. Results are means 6 standard deviation
(SD) of the mean of at least two independent experiments.
(D) Treatment of wt,Sufu2/2 cell line #1, andPtch12/2MEFs with 1 mM of the PKA inhibitor H-89 (light shaded columns) and 100 mM forskolin (dark
shaded column), transfected with a constitutively active PKA subunit expression plasmid (black column) or untreated (open column) for 1 day prior
to measuring 83GliLuc reporter activity. Results are means 6 standard deviation (SD) of the mean of at least three independent experiments.
(E) Confocal images of wt, Sufu2/2 cell line #1, and Ptch12/2MEFs after transient transfection with expression plasmids for EGFP::GLI1 or EGFP
alone for 24 hr with or without 10 ng/ml Leptomycin B (LMB) treatment for 6 hr. Nuclei are stained blue.
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192Figure 5. Sufu+/2 Mice Develop a Skin Phenotype with Gorlin-like
Features
(A and B) Ventral view of a wild-type (wt) and a Sufu+/2 mouse, the
latter showing alopecia and increased pigmentation.
(C and D) Paws from a wt and a Sufu+/2 mouse, the latter displaying
increased pigmentation and skin papules.
(E and F) Tails from a wt and a Sufu+/2 mouse, the latter with in-
creased pigmentation and skin nodules.
(G and H) Hematoxylin-eosin (H&E)-stained paw sections from a wt
and a Sufu+/2 mouse, the latter showing several epidermal basaloid
proliferations (arrowheads). The scale bar is 100 mm.
(I and J) Paw tissue sections from a wt and a Sufu+/2 mouse immu-
nostained against Ki67, the latter demonstrating relatively few pos-
itive cells in the epidermal proliferations (arrows). The scale bar is
100 mm.of proteins with a nuclear export signal, a process that can
be blocked by Leptomycin B (LMB). To investigate
whether the cytoplasmic localization of GLI1 in the
Sufu2/2 MEFs is dependent on active nuclear export, we
treated EGFP::GLI1-transfected MEFs with LMB and ob-
serveda strong nuclear retention of the EGFP::GLI1 fusion
protein regardless of MEF genotype (Figure 4E). The con-
trol EGFP subcellular localization remained unchanged
upon LMB treatment (data not shown).
Sufu+/2 Mice Develop a Skin Phenotype
with Gorlin-like Features
Having established that homozygous inactivation of
Sufu in mouse embryos and MEFs results in constitutive
and seemingly full activation of the Hh signaling path-
way, we asked if any Hh-related phenotypic changes
are present in Sufu+/2 mice. Such mice are born at the
expected Mendelian ratio, appear normal at birth,
show normal growth, and are fully fertile.
However, a distinct skin phenotype with 100% pene-
trance (43/43 mice examined) developed in the Sufu+/2
mice. This phenotype is macroscopically characterized
by ventral alopecia (Figure 5B), increased pigmentation
(Figures 5B, 5D, and 5F), and papules and nodules on
the paws and tail (Figures 5D and 5F); is macroscopically
visible from w1.5 years of age; and becomes more se-
vere in older mice. The earliest microscopic alterations
were seen as small basaloid evaginations arising from
the basal epidermal cells on the palmar aspect of the
paws, at about 6 months of age. By 2 years of age, alter-
ations were found in all skin areas (Figure 5H and Figures
S5G and S5H). Immunohistochemical staining for the
proliferation marker Ki67 revealed a relatively low num-
ber of positive cells (Figure 5J), consistent with the ob-
served slow growth of these changes. Additional char-
acterization of the skin phenotype can be found in the
Supplemental Data. Furthermore, we frequently ob-
served the appearance of mandibular keratocysts in
the Sufu+/2 mice (Figure 5L), which is a typical finding
in Gorlin patients.
Overexpression of the Hh effectors GLI1 and Gli2
(Hutchin et al., 2005; Nilsson et al., 2000) as well as a con-
stitutively active form of Smo (Grachtchouk et al., 2003)
in mouse skin drives the development of a range of hair
follicle-associated lesions with phenotypes correlating
to different levels of Gli expression. To investigate
whether increased Hh signaling is underlying the ap-
pearance of skin lesions in Sufu+/2 mice, we measured
the levels of Gli1 expression by quantitative real-time
PCR in the skin ofw2-year-old Sufu+/2 and wt mice on
a mixed B6;129 background. Three out of three tested
Sufu+/2 mice showed a 9.8- to 16.2-fold increase in
Gli1mRNA levels compared to age-matched wt controls
(Figure 6B). Moreover, in younger mice with less ad-
vanced proliferations, w1 year old on a B6 congenic
background (N7), smaller, but still significant, increases
(4.2- to 9.6-fold) were found in four out of four Sufu+/2
mice compared to wt control (Figure 6A). Thus, the in-
crease in Gli1 expression levels correlate with the extent
(K and L) H&E-stained jaw sections from a wt and a Sufu+/2 mouse,
the latter with a keratocyst (arrow). The scale bar is 50 mm. All mice
are around 2 years of age.
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son of skin manifestations in heterozygous Ptch1 and
Sufu mice on the same genetic background reveals
that the skin phenotype is tied to Sufu haploinsuffi-
ciency; very few Ptch1+/2 mice developed these skin
manifestations.
Discussion
In this study, we have addressed the role of Sufu in the
mammalian Hh signaling pathway by using gene target-
ing in the mouse. Surprisingly, we found that Sufu
knockouts are embryonic lethal and show strong simi-
larities with Ptch1 knockouts (Goodrich et al., 1997),
and that Hh signaling is strongly activated in a ligand-
independent manner in Sufu2/2 cells. Moreover, Sufu+/2
mice develop a skin phenotype with many features
found in Gorlin syndrome. Furthermore, no support for
a direct role of Sufu in the Wnt pathway was found
(see the Supplemental Data).
Comparable Ligand-Independent Activation
of Hh Signaling in Sufu and Ptch1 Mutants
There is a remarkable agreement between the Sufu2/2
and Ptch12/2 embryos in terms of the spatiotemporal
expression pattern of all the markers examined both in
the whole-mount embryo and neural tube analysis.
High-level expression of the Ptch1 and Gli1 target genes
Figure 6. Skin from Sufu+/2 Mice Express Increased Levels of Gli1,
Indicative of an Active Hh Pathway, and Genetic Diagrams Depicting
the Divergence of Core Components in the Pathway in Insects ver-
sus Mammals
(A and B) Real-time quantitative PCR for Gli1 expression in wt (filled
columns) and Sufu+/2 (open columns) skin around (A) 1-year-old
mice on a B6 genetic background (generation N7) or (B) 2-year-old
mice on a mixed B6;129 background. Gli1 expression is presented
relative to wt skin, which was given an arbitrary level of 1.0, after nor-
malizing the samples with the mouse GAPDH as an endogenous
control. Results are means6 standard deviations of samples in trip-
licate.
(C) InDrosophila, themajorpathwaycontrollingCidownstreamofSmo
is mediated via Cos2, while the pathway via Su(fu) has a less important
role. In the mouse, a major postreceptor mechanism controlling Gli ac-
tivity is mediated by Sufu, as we have demonstrated in this paper.in the Sufu2/2 embryos suggests that Sufu is endowed
with a strong repressor activity, removal of which
causes ectopic activation of the Hh pathway. It should
be emphasized that in the ventralized spinal cord from
the Sufu2/2 embryos, prominent ectopic expression of
target genes such as FoxA2 and Nkx2.2, which require
the highest levels of Hh signaling, is evident (Stamataki
et al., 2005). Evidently, this high Hh activity is dominant
in patterning the neural tube over the dorsalizing signals
mediated by the Bmp proteins, which normally act in an
antagonizing manner to Shh in the neural tube (Liem
et al., 1995). Taken together, this indicates that mamma-
lian Sufu, in striking contrast to the situation inDrosoph-
ila, is an equally strong repressor of the Hh pathway, as
Ptch1 and removal of either one is sufficient to induce
a similar high level of cell autonomous Hh signaling.
Recently, another study describing a different Sufu
mutant allele was published (Cooper et al., 2005). Their
homozygous mutant embryo phenotype generally
agrees with ours in that the embryos die at the same
stage with similar defects.
Mechanistic Insights into the Role
of Mammalian Sufu
Based on studies of the effects of activators and inhibi-
tors (SAG and cyclopamine, respectively) of Smo activ-
ity in the Sufu2/2 MEFs, it appears that these cells have
uncoupled the upstream ligand-dependent activation of
Smo from the downstream Gli activity. This observation
further suggests that constitutive activation of Hh sig-
naling in cells lacking Sufu is determined by their intrin-
sic competence for Hh response and not actual expo-
sure to Hh ligands. This independence of Hh ligand is
further demonstrated in mouse Sufu2/2; Shh2/2 double
mutant embryos, which appear morphologically similar
to the Sufu2/2 mutants (unpublished data). Additional
support for this conclusion is presented in an accompa-
nying paper (Varjosalo et al., 2006 [this issue ofDevelop-
mental Cell]), where it is shown that downregulation of
Sufu levels by RNAi in NIH-3T3 or Smo2/2 cells results
in activation of Hh signaling.
Activation of PKA inhibits Hh pathway activity in mam-
malian cells, and phosphorylation of T374 in Gli1, asso-
ciated with modulation of the adjacent nuclear localiza-
tion signal, was recently proposed to mediate at least
part of this effect (Sheng et al., 2005). In Ptch12/2
MEFs, PKA activation effectively inhibited Gli reporter
gene activity, whereas, in Sufu2/2 MEFs, only partial in-
hibition was observed. This suggests that the full repres-
sive effect of PKA activation on the Hh pathway is due to
more than one mechanism and targets additional Hh
pathway components.
From the proposed function for Sufu, one would have
expected to see an increased nuclear accumulation of
EGFP::GLI1 in the Sufu2/2 MEFs. However, this is not
evident from our data. On the contrary, the steady-state
EGFP::GLI1 localization remains predominantly cyto-
plasmic and becomes nuclear only after the nuclear ex-
port process is blocked by LMB. This indicates that
there is a highly effective shuttling of GLI1 protein out
of the nucleus, and only when you block the nuclear ex-
port is there a detectable accumulation regardless of
whether Sufu is present. We interpret these results to
suggest that Sufu’s primary role is not to retain GLI1 in
Developmental Cell
194the cytoplasm, but rather to mediate repression of Gli-
dependent transcription in the nucleus (Cheng and
Bishop, 2002; Kogerman et al., 1999).
Evolutionary Divergent Role of Sufu in Hh Signaling
The severe functional consequences and the high level
of Hh signaling caused by deleting the Sufu gene in
the mouse was surprising given the overall conservation
of the Hh pathway during evolution and the lack of an al-
tered phenotype in the corresponding Drosophila mu-
tants (Preat, 1992). Recently, another unanticipated re-
sult was revealed when a possible mouse ortholog of
Drosophila Fuwas targeted and no apparent Hh-depen-
dent phenotypes during embryonic development were
seen (Chen et al., 2005; Merchant et al., 2005). In con-
trast, Drosophila fu mutants are embryonic lethal (Preat
et al., 1993), and, in zebrafish, MO knockdown of Fu ab-
rogated Hh-dependent specification of myotome cell
types (Wolff et al., 2003). Moreover, genetic inactivation
(Koudijs et al., 2005) or MO knockdown of Sufu in zebra-
fish (Wolff et al., 2003) results in a detectable Hh-related
phenotype, but the effect is much weaker than that
caused by elimination of Ptc. In contrast, our data pre-
sented here indicate that, in the mouse, null mutations
of Sufu and Ptch1 produce equally strong perturbations
of the Hh pathway. This suggests that not only has the
Hh pathway evolved differently in vertebrates compared
to invertebrates, but also within vertebrates, since mam-
mals and teleosts show divergence in the pathway. An-
other such example of differences in the Hh pathway is
illustrated by the recent finding that intraflagellar trans-
port (IFT) proteins are required for transduction of the
Hh signal in the mouse (Huangfu and Anderson, 2005;
Huangfu et al., 2003; Liu et al., 2005), whereas analysis
of IFT mutants in zebrafish (Sun et al., 2004; Tsujikawa
and Malicki, 2004) and Drosophila (Han et al., 2003; Sar-
pal et al., 2003) did not reveal any Hh-dependent pheno-
types. A model depicting the genetic interaction in mam-
mals in comparison to the fly is shown in Figure 6C. This
fundamental divergence in regulatory mechanisms has
several important implications. In the fly, it is presently
believed that Su(fu) together with the atypical kinesin
Cos2 represent intracellular negative regulators of Hh
signaling (Hooper and Scott, 2005) and that Cos2 plays
a major role by tethering the transcriptional effector Ci
to microtubules and, in the absence of ligand, promotes
processing of Ci to its truncated repressor form. Upon
ligand stimulation, a direct interaction between the
C-terminal tail of Smo and Cos2 is enhanced, leading
to inhibition of Ci processing and nuclear availability of
activated full-length Ci. Su(fu), on the other hand, re-
sides mostly in a separate intracellular complex also
containing Ci (Lum et al., 2003; Stegman et al., 2000)
and functions both to tether Ci in the cytoplasm and
to inhibit activated full-length Ci (Methot and Basler,
2000; Wang et al., 2000). However, even in the absence
of Su(fu), Cos2 is able to sequester Ci in the cytoplasm
and maintain normal regulation of Hh signaling,
whereas, in the absence of Cos2, constitutive activation
of Ci ensues (Wang et al., 2000). In the mouse, Sufu loss
alone leads to complete activation of the Hh signaling
pathway, and mice therefore may not utilize a Cos2-
like activity that in Drosophila is sufficient to maintain
Hh pathway regulation in the absence of Sufu. Thus,when Sufu is removed, unrestrained Gli-mediated tran-
scriptional activation is allowed by eliminating repres-
sion mechanisms normally inhibiting Gli activity. In
mammalian cells, Gli1 and Gli2 serve mainly as positive
transcriptional regulators, whereas Gli3 is processed
and, for the most part, acts as a repressor (Ingham
and McMahon, 2001). Since Sufu can interact with the
N-terminal part of Gli proteins and the Sufu binding motif
is retained in the Gli3 repressor form (Dunaeva et al.,
2003), it appeared likely that Sufu also exerts a negative
influence on the repressor activity of Gli3. Since we find
a strong activation of Hh signaling in cells lacking Sufu in
vivo and in vitro, we propose that Gli-mediated tran-
scriptional activation is dominant over Gli-mediated re-
pression. Alternatively, this result may be due to the
fact that Sufu, in analogy to the situation with Gli1 (Mer-
chant et al., 2004), must interact with two different do-
mains on Gli3, one of which is missing in the Gli3 repres-
sor form, to achieve effective repression. This result may
also be due to differential expression domains for the
activating and repressive Gli isoforms.
Sufu+/2 Mice Develop Features of Gorlin Syndrome
The phenotypes we observe in the Sufu+/2 mice are in
good agreement with the proposed role of Sufu as a reg-
ulator of Hh signaling. In patients with Gorlin syndrome
(nevoid basal cell carcinoma syndrome [NBCCS]; MIM
#109400), an autosomal dominant disorder in which
one mutated copy of PTCH1 is inherited (Gorlin, 2004;
Hahn et al., 1996; Johnson et al., 1996), jaw keratocysts
and skin changes, mostly in the form of basal cell carci-
nomas (BCCs) and palmar/plantar pits, but also includ-
ing basaloid follicular hamartomas (BFHs), (Oseroff
et al., 2005) are typical and dominant lesions. In the ag-
ing Sufu+/2 mice, basaloid skin changes, pit-like lesions
in the paws, and jaw keratocysts all correspond to sim-
ilar lesions found in Gorlin patients, although the skin
changes appear more like BFHs than typical BCCs.
Thus, the Sufu+/2 mouse represents a valuable and
complementing animal model of this human disease.
The reason that the Sufu+/2 mice do not get typical
BCCs is possibly because the levels of Gli activity
needed for BCCs to develop is not reached in the
Sufu+/2 skin due to the level of regulation still offered
by the remaining wt Sufu allele. Support for this notion
comes from mouse models in which the severity of
skin alterations is linked to the level of Gli activity
(Grachtchouk et al., 2003; Nilsson et al., 2000). Similarly,
BCCs do not develop spontaneously in the Ptch1+/2
mice unless they are irradiated with UV light or ionizing
radiation (Aszterbaum et al., 1999). In fact, the observed
skin changes are more prominent in the Sufu+/2 mice
than in thePtch1+/2mice (data not shown). The observa-
tion that the skin lesions express K17 and that we see
the appearance of abortive hair follicle formation sug-
gest that there is an expansion of primitive progenitor
cells, a concept that is in line with data from studies of
mice conditionally expressing Gli2 in the skin (Hutchin
et al., 2005). In the few human patients reported with
germline mutations in SUFU, no skin phenotypes were
reported, possibly due to the patients’ young age or
the nature of mutations (Taylor et al., 2002). However,
differential penetrance of this phenotype between
mice and humans remains a possibility.
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ings, no phenotypic changes in the heterozygous Sufu
mutant mice were observed. One possible explanation
could be mouse strain background differences since
we differ in the 129 substrain used (129X1/SvJ versus
129S1/Sv) and in the source of C57BL/6 (Jackson Labo-
ratories versus Charles River). Another possible expla-
nation concerns how the alleles were targeted; we have
deleted exon 1 along with the promoter, and Cooper
et al. (2005) have deleted part of exon 7. It cannot for-
mally be excluded that a C-terminally truncated Sufu
protein is being made from the mutant allele reported
by Cooper et al. (2005). If such a truncated protein has
some residual activity, this may be enough to rescue the
heterozygous (but apparently not the homozygous) mu-
tant phenotype that we observe. In fact, a recent study
reports that the N-terminal part of Sufu is sufficient to in-
hibit Gli-dependent transcription (Barnfield et al., 2005).
Concluding Remarks
The results presented in this study highlight an impor-
tant evolutionary divergence in the basic regulatory cir-
cuits controlling Hh signaling, a pathway having a key
role in development and human disease, including can-
cer, thereby illustrating the need to understand in detail
the function of the pathway in mammalian systems. The
unanticipated role of Sufu as a specific and potent re-
pressor of Hh signaling also opens new therapeutic av-
enues to control deregulated Hh pathway activation, for
example, by development of Sufu mimetics.
Experimental Procedures
Mouse Strains
Generation of theSufumutant mouse strain is described in the Supple-
mental Data, and this strain was provisionally designated B6;129X1/
SvJ-Sufutm1Rto. The Ptch1 knockout mice (B6;129-Ptch1tm1Mps)
were obtained from The Jackson Laboratory (stock 003081). The
mice were housed in an SPF barrier facility according to local and na-
tional regulations, and conditions were approved by the Stockholm
South Animal Ethics Committee.
Generation of MEF Cell Lines
Immortalized mouse embryo fibroblast (MEF) cell lines were estab-
lished by using a 3T3-like protocol (Todaro and Green, 1963). Briefly,
E9.5 embryos were incubated for 5 min in 0.05% trypsin-EDTA (Invi-
trogen) at 37ºC, medium was added, embryos were resuspended
before plating onto tissue culture dishes and were passaged until
crisis, and, eventually, immortal cells appeared. The MEF medium
consisted of D-MEM (high glucose, w/o sodium pyruvate), heat-
inactivated 10% fetal bovine serum (FBS), 2 mM L-glutamine,
1 mM sodium pyruvate, and 10 mg/ml gentamicin, all from Invitrogen.
The Ptch12/2 MEFs, derived in a similar manner, were a kind gift
from Dr J. Taipale, University of Helsinki, Finland.
Northern Blot Analysis, RT-PCR, and Real-Time
Quantitative PCR
For the Northern analysis, total RNA from E8.5 and E9.5 embryos
were prepared by using the RNeasy kit (Qiagen). Embryos were col-
lected in RNAlater (Ambion) prior to preparation. For the Northern
gel, 15 mg total RNA per lane was separated on a 1% formalde-
hyde-containing agarose gel and was transferred to Nytran Super-
charge membranes (Schleicher & Schuell) in NorthernMax transfer
buffer (Ambion) followed by UV crosslinking. The radioactively la-
beled probes consisted of a 1.2 kb mouse Sufu cDNA XhoI/NotI frag-
ment from an EST clone (GenBank accession number AA754906)
and a 1076 bp mouse b-actin cDNA fragment (Ambion). Prehybrid-
izations were conducted for 1–2 hr, and hybridizations were con-
ducted for 2–3 hr at 65ºC in ULTRAhyb (Ambion), followed by threewashes at 65ºC in Low Stringency Buffer 1 (Ambion) and two washes
at 65ºC in High Stringency Buffer 2 (Ambion).
For the RT-PCR analysis, total RNA from confluent MEF cells or
embryos (Actr1a analysis) were prepared as described above with
RNase-free DNaseI (Qiagen) treatment and were reverse transcribed
into cDNA by using SuperScript (Invitrogen). PCR amplifications
were performed with primers against mouse Ptch1, Ptch2, Smo,
Sufu, Gli1, Gli2, Actr1a, Hprt, and Actr1a (see the Supplemental
Data, Table S1).
For the real-time quantitative PCR, total RNA from freshw1-year-
old Sufu+/+ and Sufu+/2 skin tissue on a B6 congenic background
(N7) or frozen w2-year-old Sufu+/+ and Sufu+/2 skin tissue on
a mixed B6;129 background were prepared (Chomczynski and Sac-
chi, 1987). The RNA samples were treated with RNase-Free DNaseI
(Promega) and were reverse transcribed with SuperScript
(Invitrogen) with oligo(dT)15 primers. The reactions were made up
in TaqMan Universal PCR master mix (Applied Biosystems) with
TaqMan Gene Expression Assays for mouse Gli1 (assay ID
#Mm00494645_m1) and endogenous control mouse GAPDH
(#4352339E) and were analyzed on an ABI PRISM 7700 Sequence
Detection System (Applied Biosystems). Samples were analyzed in
triplicate for each dilution and were normalized to GAPDH in each
sample before calculating relative Gli1 mRNA levels.
Western Blot Analysis and ECL Detection
Total cell lysates from E9.5 embryos pooled according to genotype
were prepared in extraction buffer (pH 7.6 at 4ºC containing 1% Tri-
ton X-100, 10 mM Tris-HCl, 5 mM EDTA, 50 mM NaCl, 30 mM Na-
pyrophosphate, 50 mM NaF, 1 mM Na3VO4, 10% glycerol, and com-
plete protease inhibitor cocktail [Roche]). The Triton X-100 was
added after tissue homogenization by using an Ultra-Turrax T8
(IKA). Protein extracts were quantified with the DC protein assay
(Bio-Rad). A total of 15 mg total protein per genotype and lane in
13 Laemmli sample buffer was separated on an 8% SDS-PAGE
gel by using a Protean II xi Cell (Bio-Rad) and was transferred to
a Hybond-ECL membrane (Amersham Biosciences) with a Trans-
Blot apparatus (Bio-Rad). The protein membrane was subjected to
ECL analysis (Amersham Biosciences) by using a primary polyclonal
antibody against Sufu (1:200, sc-10933, Santa Cruz Biotechnology)
and a secondary bovine a-goat IgG-HRP (1:2000, sc-2350, Santa
Cruz Biotechnology). The chemiluminescent reaction was detected
on Hyperfilm ECL (Amersham Biosciences). After stripping the
membrane, protein loading was verified by using a primary mono-
clonal b-actin antibody (1:5000, A5441, Sigma) and a secondary
sheep a-mouse IgG-HRP (1:5000, NA-931, Amersham Biosciences).
Scanning Electron Microscopy, In Situ Hybridizations,
and Histochemistry
For the scanning electron microscopy, embryos were fixed in 2%
glutaraldehyde, dehydrated in ascending concentrations of ethanol,
dried by critical point, and mounted on aluminum stubs. After coat-
ing with 15 nm platinum, the samples were analyzed in a Jeol JSM-
820 scanning electron microscope operating at 15 kV.
Whole-mount in situ hybridization was performed on E8.5 and E9.5
paraformaldehyde-fixed embryos (Henrique et al., 1995). Mouse an-
tisense and sense (control) RNA probes were prepared by using DIG
RNA labeling mix (Roche) together with T3, T7, or SP6 RNA polymer-
ases (Roche). The linearized plasmids used as templates for the
in vitro transcription were mouse cDNA fragments for Shh (0.6 kb in
pBS II KS+), Ptch1 (841 bp in pBS II KS+), Sufu (987 bp in pBS SK-),
Gli1 (552 bp in pBS II KS+), Gli2 (1.0 kb in pBS II KS+), Gli3 (1.1 kb
in pBS II SK+), and Axin2/Conductin (637 bp in pBS II SK+). The
Shh-hybridized embryos were paraffin embedded and sectioned.
Immunohistochemical localization of proteins in the neural tube
was performed as described (Briscoe et al., 2000; Yamada et al.,
1993). Antibodies against Shh, Nkx2.2, FoxA2, and Pax6 were ob-
tained from the Developmental Studies Hybridoma Bank. The
Nkx6.1 (Jensen et al., 1996) and Isl1/2 antibodies (Thor et al., 1991)
have been described. NK1R antisera (s8305, Sigma) were a kind
gift from Dr. G. Fortin, France. Images were collected with a Zeiss
LSM510 confocal microscope.
In situ hybridization of neural tube sections was performed as de-
scribed (Schaeren-Wiemers and Gerfin-Moser, 1993) by using DIG-
labeled cRNA probes for mouse Ptch1, Gli3, and Nato3 (Segev
et al., 2001).
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were fixed in 10% neutral-buffered formalin (Sigma) or Bouin’s solu-
tion (Sigma), and they were subsequently paraffin embedded, sec-
tioned at 4–5 mm, and stained with hematoxylin-eosin or followed
by immunohistochemistry (see the Supplemental Data).
Luciferase Reporter Assays
For the luciferase reporter assays, 20,000 MEF cells were seeded into
each well of a 24-well plate in MEF medium. The following day, cells
were transfected with FuGENE 6 (Roche) with 300 ng of the luciferase
reporter plasmids 83GliLuc and 83GlimutLuc (Sasaki et al., 1997)
with or without 300 ng of the pMYC-SUFU expression plasmid
(Kogerman et al., 1999), 300 ng of a constitutively active PKA catalytic
subunit expression plasmid (Taipale et al., 2000), or 300 ng of the
TOPflash and FOPflash reporter plasmids (Upstate Biotechnology),
together with 50 ng of the Renilla luciferase phRL-TK reporter
(Promega) to monitor the transfection efficiency. Two days after
transfection, the medium was changed to low serum (0.5% FBS)
with or without 10 mM cyclopamine in DMSO (Toronto Research
Chemicals, Inc.), 100 nM Smoothened agonist (SAG) in methanol
(provided by Dr J. Bergman, Karolinska Institutet, Sweden), 100 mM
forskolin (Sigma) in DMSO, 1 mM H-89 (Sigma) in DMSO, or with
DMSO alone and was incubated for 1–3 days before the cells were
assayed with the Dual-Reporter Luciferase system (Promega) and
the samples were analyzed on a Luminoskan Ascent microplate
luminometer (Thermo Electron Corp.). The assays were conducted
in triplicate and repeated at least three times. The values were nor-
malized to the Renilla reporter before calculating relative levels.
GLI1 Subcellular Localization in MEFs
Wt, Sufu2/2, and Ptch12/2 MEFs (1 3 106 cells) were each trans-
fected with 5 mg of the expression constructs containing GLI1
cDNA fused in frame 30 of EGFP (EGFP::GLI1 [Kogerman et al.,
1999]) or with the parental EGFP plasmid alone (BD Biosciences
Clontech) in MEF 1 solution by using Nucleofector technology, pro-
gram T-20 (Amaxa Biosystems), and cells were seeded onto slide
chambers, followed by culturing overnight. Twenty-four hours after
transfection, cells were either treated with 10 ng/ml Leptomycin B
(Sigma) for 3–6 hr or left untreated, washed in PBS, fixed in 4%
PFA, washed in PBS again, and incubated with DRAQ5 (Alexis Bio-
chemicals) for visualization of cell nuclei, followed by mounting with
ProLong Gold antifade reagent (Invitrogen). Fluorescence was visu-
alized with a Zeiss LSM510 confocal microscope with lasers set at
488 nm for EGFP and at 633 nm for DRAQ5.
Supplemental Data
Supplemental Data including Supplemental Results, Supplemental
Experimental Procedures, five figures, one table, and references
are available at http://www.developmentalcell.com/cgi/content/
full/10/2/187/DC1/.
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